Allergy Therapeutics plc's Buy Rating Reaffirmed at Panmure Gordon

‘s stock had its “buy” rating reissued by investment analysts at Panmure Gordon in a note issued to investors on Tuesday, Analyst Ratings.Net reports. They presently have a GBX 47 target price on the stock.